Event

Artificial intelligence is rapidly changing the pace of scientific discovery. As AI becomes increasingly capable of generating hypotheses, designing molecules and proposing experiments at unprecedented speed,…

Clinical development leaders from Accenture, Novartis, Roche and Biorce discuss where AI agents can create real value in clinical development, and what needs to change…

Multi-omics technologies are unlocking deeper biological insight – but the real inflection point is not volume. Instead, the field is moving towards integration: in other…

As bioconvergence reshapes the life sciences, a growing movement is redefining how we test and develop new therapies by shifting from animal models to human-relevant…